Ardelyx (ARDX) Short-term Investments (2016 - 2026)
Ardelyx (ARDX) posted Short-term Investments of $206.9 million for Q1 2026, up 5.17% on a QoQ basis from $196.7 million in Q4 2025, and up 12.95% year-over-year from $183.1 million in Q1 2025.
Ardelyx (ARDX) Short-term Investments (2016 - 2026) Analysis & Trends
Ardelyx's Short-term Investments history runs 11 years deep, the most recent figure standing at $206.9 million for Q1 2026.
- Quarterly Short-term Investments rose 12.95% year-over-year to $206.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $206.9 million (up 12.95% YoY) and the FY2025 annual result came in at $196.7 million, up 6.22% from the prior year.
- Short-term Investments was $206.9 million for Q1 2026 at Ardelyx, up from $196.7 million in the prior quarter.
- Across five years, Short-term Investments topped out at $206.9 million in Q1 2026 and bottomed at $27.6 million in Q2 2022.
- A 5-year average of $125.3 million and a median of $144.1 million in 2024 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2022 — Short-term Investments tumbled 67.55% — and 2023, when it jumped 486.37%.
- Ardelyx's Short-term Investments stood at $27.8 million in 2022, then soared by 486.37% to $162.8 million in 2023, then rose by 13.72% to $185.2 million in 2024, then increased by 6.22% to $196.7 million in 2025, then rose by 5.17% to $206.9 million in 2026.
- Business Quant data shows ARDX's Short-term Investments at $206.9 million in Q1 2026, $196.7 million in Q4 2025, and $200.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206.87 Mn |
| Dec 31, 2025 | 196.69 Mn |
| Sep 30, 2025 | 199.99 Mn |
| Jun 30, 2025 | 148.41 Mn |
| Mar 31, 2025 | 183.14 Mn |
| Dec 31, 2024 | 185.17 Mn |
| Sep 30, 2024 | 142.97 Mn |
| Jun 30, 2024 | 144.07 Mn |
| Mar 31, 2024 | 166.43 Mn |
| Dec 31, 2023 | 162.83 Mn |
| Sep 30, 2023 | 131.31 Mn |
| Jun 30, 2023 | 97.52 Mn |
| Mar 31, 2023 | 37.89 Mn |
| Dec 31, 2022 | 27.77 Mn |
| Sep 30, 2022 | 29.00 Mn |
| Jun 30, 2022 | 27.60 Mn |
| Mar 31, 2022 | 42.63 Mn |
| Dec 31, 2021 | 44.26 Mn |
| Sep 30, 2021 | 66.36 Mn |
| Jun 30, 2021 | 85.06 Mn |